Vyne Therapeutics Inc (VYNE)

07:21 AM

VYNE stock holds its ground. Focus turns to the company profile. - AD HOC NEWS

07:21 AM

Jul 05, 2026

VYNEVYNE Therapeutics Inc Forecast, Target Price - Finviz

Jul 05, 2026

Jul 02, 2026

Form 4 Vyne Therapeutics Inc For: 2 July By Investing.com - Investing.com Nigeria

Jul 02, 2026

Jul 02, 2026

VYNE (VYNE) CFO reports 3,464-share tax withholding on RSU vesting - Stock Titan

Jul 02, 2026

Jul 02, 2026

VYNE Therapeutics (VYNE) CLO has shares withheld to cover RSU taxes - Stock Titan

Jul 02, 2026

Jul 02, 2026

VYNE (VYNE) CEO Domzalski has 12,214 shares withheld for RSU taxes - Stock Titan

Jul 02, 2026

Jun 27, 2026

Price to book forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView

Jun 27, 2026

Jun 27, 2026

Price to earnings forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView

Jun 27, 2026

Jun 27, 2026

Price to sales forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView

Jun 26, 2026

Jun 26, 2026

VYNE Therapeutics Inc Actuals & Estimates (NASDAQ:VYNE) - TradingView

Jun 26, 2026

Jun 25, 2026

VYNE Therapeutics Inc Actuals & Estimates (BOATS:VYNE) - TradingView

Jun 25, 2026

Jun 22, 2026

Vyne Therapeutics Inc (VYNE) Institutional Confidence - TradingKey

Jun 22, 2026

Jun 21, 2026

VYNE Therapeutics StockSunday background on a micro-cap dermatology player - AD HOC NEWS

Jun 21, 2026

Jun 19, 2026

Vyne Therapeutics Inc (VYNE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 19, 2026

Jun 19, 2026

Vyne Therapeutics Inc (VYNE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 19, 2026

Jun 19, 2026

Vyne Therapeutics Inc (VYNE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 19, 2026

Jun 17, 2026

Vyne Therapeutics Inc (VYNE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026

Jun 17, 2026

Vyne Therapeutics Inc (VYNE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Vyne Therapeutics Inc (VYNE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Vyne Therapeutics Inc (VYNE) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Vyne Therapeutics Inc (VYNE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

[EFFECT] VYNE Therapeutics Inc. SEC Filing - Stock Titan

Jun 17, 2026

Jun 15, 2026

VYNE (VYNE) merger with Yarrow: $100M financing, 35.8441 exchange ratio - Stock Titan

Jun 15, 2026

Jun 15, 2026

Zhang Xiaofan discloses 1.87M shares (5.6%) in VYNE Therapeutics (VYNE) - Stock Titan

Jun 15, 2026

Jun 12, 2026

VYNE Q1 2026 Earnings: EPS Beat Estimate, No Revenue ReportedFinancial Summary - newsline.com

Jun 12, 2026

Jun 08, 2026

VYNE Therapeutics (VYNE) Edges Higher in Quiet Trading, Testing Key Resistance at $0.69New Listing Stocks - newsline.com

Jun 08, 2026

Jun 06, 2026

VYNE Therapeutics (VYNE) Consolidates Near Support After Slight PullbackMACD Signal Stocks - newsline.com

Jun 06, 2026

Jun 02, 2026

[Form 4] VYNE Therapeutics Inc. Insider Trading Activity - Stock Titan

Jun 02, 2026

Jun 01, 2026

VYNE Therapeutics (VYNE) Posts Modest Gain, Holds Above Key SupportMotive Wave - newsline.com

Jun 01, 2026

May 29, 2026

VYNE Therapeutics (VYNE) Edges Lower as Shares Test Key Support Near $0.65Standard Deviation - thelegaladvocate.com

May 29, 2026

May 28, 2026

RKTO Stock Price and Chart — NASDAQ:RKTO - TradingView

May 28, 2026

May 21, 2026

VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline - TipRanks

May 21, 2026

May 21, 2026

VYNE to Advance YB-101 into Phase 2 in Q2 2026; $200M Raised, Phase 2a Readout Expected H2 2027 - TradingView

May 21, 2026

May 21, 2026

Yarrow reverse merger refocuses VYNE (NASDAQ: VYNE) with $200M war chest - Stock Titan

May 21, 2026

May 18, 2026

VYNE Therapeutics (VYNE) price target decreased by 38.46% to 2.04 - MSN

May 18, 2026

May 17, 2026

VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 17, 2026

May 15, 2026

Nantahala (NASDAQ: VYNE) reports 2,000,000-share stake representing 6.00% - Stock Titan

May 15, 2026

May 15, 2026

Yarrow merger to refocus VYNE (NASDAQ: VYNE) with $200M financing - Stock Titan

May 15, 2026

May 15, 2026

MSN Money - MSN

May 15, 2026

May 15, 2026

VYNE: Net loss narrowed 58% year-over-year as R&D spending dropped ahead of the Yarrow merger - TradingView

May 15, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 04, 2026

Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

The regulatory exposure in VYNE Therapeutics (VYNE) results | Q4 2025: Earnings Beat EstimatesNon-GAAP Earnings - The Legal Advocate

May 03, 2026